大腸がん分子診断の世界市場レポート 2025年

大腸がん分子診断市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.1％で37億9,000万米ドルに成長します。予測期間の成長は、人口の高齢化とリスク要因の増加、ゲノムデータの臨床への統合、精密医療アプローチの台頭、がん研究と共同研究における世界の取り組みに起因すると考えられます。予測期間における主な動向には、早期発見バイオマーカーの重視、データ解析における人工知能（AI）の統合、循環腫瘍DNA（CTDNA）解析の増加、標的治療用コンパニオン診断の拡大、免疫療法バイオマーカーの重視などがあります。

炎症性腸疾患（IBD）の罹患率の上昇が、今後の大腸がん分子診断市場の成長を牽引すると予測されています。炎症性腸疾患（IBD）は、主に結腸と直腸を侵す消化管の炎症によって特徴づけられる慢性消化管疾患であり、腹痛、下痢、体重減少などの症状を伴う。これらの疾患は通常、薬物療法、生活習慣の改善、時には手術によって管理されます。結腸直腸がん（CRC）の全身療法の決定は、腫瘍の分子評価から得られる結果に大きく依存するため、IBDの罹患率の増加は、正確で効率的かつ高度な診断ソリューションに対する需要を高めています。例えば、2024年4月にCrohn's &Colitis UKが実施した調査によると、英国では約50万人が炎症性腸疾患（IBD）を患っており、これは従来の推定値のほぼ2倍であることが明らかになりました。したがって、炎症性腸疾患（IBD）の罹患率の増加は、大腸がん分子診断市場の成長を促進すると思われます。

大腸がんの有病率の上昇が大腸がん分子診断市場の成長を牽引すると予測されます。大腸がんは結腸や直腸を侵し、これらの消化器系領域における細胞の無秩序な増殖が腫瘍形成につながります。大腸がん患者の急増は、がんの検出と治療に不可欠な分子診断ツールの需要を高めています。2023年3月に米国がん協会が強調したように、推定153,020人が大腸がんの診断を受け、約52,550人が死亡すると予測されています。この予測には50歳未満の19,550例と3,750例の死亡が含まれています。このように、大腸がんの有病率の上昇は、大腸がん分子診断市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の大腸がん分子診断PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の大腸がん分子診断市場：成長率分析
• 世界の大腸がん分子診断市場の実績：規模と成長, 2019-2024
• 世界の大腸がん分子診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界の大腸がん分子診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の大腸がん分子診断市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬とキット
• サービス
• 世界の大腸がん分子診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• シーケンシング
• 質量分析
• 転写による増幅
• チップとマイクロアレイ
• 等温核酸増幅技術（INAAT）
• 世界の大腸がん分子診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 診断検査室
• ホームケア設定
• 世界の大腸がん分子診断市場、楽器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCRマシン
• シーケンサー
• マイクロアレイ
• 世界の大腸がん分子診断市場、試薬とキットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAまたはRNA抽出キット
• アッセイキット
• 試薬パック
• 世界の大腸がん分子診断市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査サービス
• 遺伝子検査サービス
• コンサルティングサービス

第7章 地域別・国別分析

• 世界の大腸がん分子診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の大腸がん分子診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 大腸がん分子診断市場：競合情勢
• 大腸がん分子診断市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Biocartis Group NV
• Agilent Technologies Inc.
• Grifols S.A
• Hologic Inc.
• Biomerieux SA
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Exact Sciences Corporation
• Illumina Inc.
• Cepheid
• Myriad Genetics Inc.
• Guardant Health
• Luminex Corporation
• GenMark Diagnostics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 大腸がん分子診断市場2029：新たな機会を提供する国
• 大腸がん分子診断市場2029：新たな機会を提供するセグメント
• 大腸がん分子診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that forms in the colon (large intestine) or rectum (final part of the digestive tract before the anus). It originates from the inner lining of these gastrointestinal segments. Colorectal cancer molecular diagnostics involve advanced techniques to identify specific genetic mutations, alterations, and biomarkers crucial for understanding the development, progression, and treatment response of colorectal cancer.

The primary components of colorectal cancer molecular diagnostics include instruments, reagents, kits, and services. Instruments are specialized tools or devices designed for analyzing and detecting molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples from patients with colorectal cancer. Molecular diagnostic solutions employ technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT). These diagnostics are utilized by various end-users, including hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.

The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer molecular diagnostics market statistics, including colorectal cancer molecular diagnostics industry global market size, regional shares, competitors with a colorectal cancer molecular diagnostics market share, detailed colorectal cancer molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. This colorectal cancer molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing incidence of colorectal cancer, growing awareness, and screening initiatives, rising emphasis on personalized medicine, government initiatives for cancer control.

The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to aging population and increased risk factors, integration of genomic data into clinical practice, rise in precision medicine approaches, global efforts in cancer research and collaboration. Major trends in the forecast period include increasing emphasis on early detection biomarkers, integration of artificial intelligence (ai) in data analysis, rise of circulating tumor DNA (CTDNA) analysis, expansion of companion diagnostics for targeted therapies, focus on immunotherapy biomarkers.

The rising incidence of inflammatory bowel diseases (IBD) is projected to drive the growth of the colorectal cancer molecular diagnostic market in the future. Inflammatory bowel diseases (IBD) are chronic gastrointestinal disorders marked by inflammation of the digestive tract, primarily affecting the colon and rectum, and are associated with symptoms such as abdominal pain, diarrhea, and weight loss. These conditions are typically managed through medications, lifestyle modifications, and sometimes surgery. The growing incidence of IBD is increasing the demand for accurate, efficient, and advanced diagnostic solutions, which are crucial since determining systemic therapy for colorectal cancer (CRC) largely depends on the results obtained from molecular assessments of the tumor. For instance, in April 2024, research conducted by Crohn's & Colitis UK revealed that approximately 500,000 people in the UK are living with inflammatory bowel disease (IBD), nearly double previous estimates. Therefore, the rising incidences of inflammatory bowel diseases (IBD) will propel the growth of the colorectal cancer molecular diagnostic market.

The escalating prevalence of colorectal cancer is forecasted to drive the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer affects the colon or rectum, resulting from the uncontrolled growth of cells in these digestive system areas, leading to tumor formation. The upsurge in colorectal cancer cases intensifies the demand for molecular diagnostic tools crucial in cancer detection and treatment. As highlighted by the American Cancer Society in March 2023, an estimated 153,020 individuals are anticipated to receive a colorectal cancer diagnosis, with around 52,550 projected deaths. This forecast includes 19,550 cases and 3,750 deaths among individuals under 50 years old. Thus, the rising prevalence of colorectal cancer is a key driver fueling growth within the colorectal cancer molecular diagnostics market.

Major companies are dedicated to pioneering innovative solutions in molecular diagnostics and personalized medicine, exemplified by the introduction of the Shield Blood Test approach for early-stage colorectal cancer detection. Guardant Health, a prominent US-based biotechnology company specializing in oncology molecular diagnostic products, launched the Shield Blood Test in May 2022. This groundbreaking blood test offers a convenient screening method involving a simple blood draw, addressing challenges associated with patient reluctance to undergo screening. The test demonstrated a sensitivity of 91% for detecting colorectal cancer and 20% for identifying advanced adenomas, with a specificity of 92%. Leveraging data from diverse cohorts comprising over 2,000 individuals with colorectal cancer, 357 with advanced adenoma, and 3,757 healthy subjects, the Shield test identifies early signals of colorectal cancer in the blood.

In July 2023, New Day Diagnostics LLC, a reputable US-based medical equipment manufacturing company, completed the acquisition of Epigenomics AG assets for an undisclosed sum. This strategic acquisition broadens New Day Diagnostics' portfolio in the realm of cancer diagnostics by acquiring intellectual property from Epigenomics AG. Notably, the acquisition includes Epi ProColon, an innovative screening technology specifically designed for the non-invasive detection of colorectal cancer. Epigenomics AG, headquartered in Germany, is a recognized player in the field of colorectal cancer molecular diagnostics, emphasizing the development of cutting-edge technologies for cancer detection.

Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the colorectal cancer molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Instruments; Reagents And Kits; Services
• 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
• 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
• Subsegments:
• 1) By Instruments: PCR Machines; Sequencers; Microarrays
• 2) By Reagents And Kits: DNA Or RNA Extraction Kits; Assay Kits; Reagent Packs
• 3) By Services: Diagnostic Testing Services; Genetic Testing Services; Consultation Services
• Companies Mentioned: Johnson & Johnson; Bayer AG; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Molecular Diagnostics Market Characteristics

3. Colorectal Cancer Molecular Diagnostics Market Trends And Strategies

4. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Colorectal Cancer Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Colorectal Cancer Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Colorectal Cancer Molecular Diagnostics Market Growth Rate Analysis
• 5.4. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM)

6. Colorectal Cancer Molecular Diagnostics Market Segmentation

• 6.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents And Kits
• Services
• 6.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Sequencing
• Mass Spectrometry
• Transcription Mediated Amplification
• Chips And Microarrays
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• 6.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Homecare Settings
• 6.4. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Machines
• Sequencers
• Microarrays
• 6.5. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Or RNA Extraction Kits
• Assay Kits
• Reagent Packs
• 6.6. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Testing Services
• Genetic Testing Services
• Consultation Services

7. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market

• 8.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Colorectal Cancer Molecular Diagnostics Market

• 9.1. China Colorectal Cancer Molecular Diagnostics Market Overview
• 9.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Colorectal Cancer Molecular Diagnostics Market

• 10.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Colorectal Cancer Molecular Diagnostics Market

• 11.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview
• 11.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Colorectal Cancer Molecular Diagnostics Market

• 12.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Colorectal Cancer Molecular Diagnostics Market

• 13.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Colorectal Cancer Molecular Diagnostics Market

• 14.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview
• 14.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Colorectal Cancer Molecular Diagnostics Market

• 15.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview
• 15.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Colorectal Cancer Molecular Diagnostics Market

• 16.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Colorectal Cancer Molecular Diagnostics Market

• 17.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Colorectal Cancer Molecular Diagnostics Market

• 18.1. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Colorectal Cancer Molecular Diagnostics Market

• 19.1. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Colorectal Cancer Molecular Diagnostics Market

• 20.1. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Colorectal Cancer Molecular Diagnostics Market

• 21.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Colorectal Cancer Molecular Diagnostics Market

• 22.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Colorectal Cancer Molecular Diagnostics Market

• 23.1. North America Colorectal Cancer Molecular Diagnostics Market Overview
• 23.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Colorectal Cancer Molecular Diagnostics Market

• 24.1. USA Colorectal Cancer Molecular Diagnostics Market Overview
• 24.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Colorectal Cancer Molecular Diagnostics Market

• 25.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview
• 25.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Colorectal Cancer Molecular Diagnostics Market

• 26.1. South America Colorectal Cancer Molecular Diagnostics Market Overview
• 26.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Colorectal Cancer Molecular Diagnostics Market

• 27.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Colorectal Cancer Molecular Diagnostics Market

• 28.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview
• 28.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Colorectal Cancer Molecular Diagnostics Market

• 29.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview
• 29.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape
• 30.2. Colorectal Cancer Molecular Diagnostics Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Biocartis Group NV
• 31.2. Agilent Technologies Inc.
• 31.3. Grifols S.A
• 31.4. Hologic Inc.
• 31.5. Biomerieux SA
• 31.6. Quidel Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Qiagen N.V.
• 31.9. Exact Sciences Corporation
• 31.10. Illumina Inc.
• 31.11. Cepheid
• 31.12. Myriad Genetics Inc.
• 31.13. Guardant Health
• 31.14. Luminex Corporation
• 31.15. GenMark Diagnostics

32. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market

34. Recent Developments In The Colorectal Cancer Molecular Diagnostics Market

35. Colorectal Cancer Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Colorectal Cancer Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Colorectal Cancer Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Colorectal Cancer Molecular Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer